Sphingosine Kinase-1 Activation Causes Acquired Resistance Against Sunitinib in Renal Cell Carcinoma Cells
出版年份 2013 全文链接
标题
Sphingosine Kinase-1 Activation Causes Acquired Resistance Against Sunitinib in Renal Cell Carcinoma Cells
作者
关键词
Renal cell carcinoma, Sunitinib, SK1, ERK
出版物
CELL BIOCHEMISTRY AND BIOPHYSICS
Volume 68, Issue 2, Pages 419-425
出版商
Springer Nature
发表日期
2013-08-21
DOI
10.1007/s12013-013-9723-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
- (2012) Olivier Cuvillier et al. Current Molecular Pharmacology
- Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome Gefitinib-resistance in non-small cell lung cancer cell lines
- (2011) H Li et al. Advances in Medical Sciences
- Sunitinib and other targeted therapies for renal cell carcinoma
- (2011) T Powles et al. BRITISH JOURNAL OF CANCER
- Immunotherapy for Renal Cell Carcinoma
- (2011) Momoe Itsumi et al. Clinical & Developmental Immunology
- Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF- B Pathway in Human Non-Small Cell Lung Cancer
- (2011) L. Song et al. CLINICAL CANCER RESEARCH
- Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells
- (2011) Gabriella Marfe et al. EXPERIMENTAL HEMATOLOGY
- Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells
- (2011) Sung-Yun Cho et al. JOURNAL OF PINEAL RESEARCH
- Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer
- (2011) Dmitri Pchejetski et al. Nature Reviews Urology
- Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
- (2011) Floriana Morgillo et al. PLoS One
- Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma
- (2011) P. Olson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells
- (2010) E. Martinelli et al. CLINICAL CANCER RESEARCH
- Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
- (2009) H. Xin et al. CANCER RESEARCH
- Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters
- (2009) S. Hu et al. CLINICAL CANCER RESEARCH
- Activated Akt Prevents Antitumor Activity of Gefitinib in Renal Cancer Cells
- (2009) Kenji Kuroda et al. UROLOGY
- Sunitinib (Sutent, SU11248), a Small-Molecule Receptor Tyrosine Kinase Inhibitor, Blocks Function of the ATP-Binding Cassette (ABC) Transporters P-Glycoprotein (ABCB1) and ABCG2
- (2008) S. Shukla et al. DRUG METABOLISM AND DISPOSITION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now